Primerica, Inc. filings document operating results and governance matters for a financial services company built around term life insurance and investment and savings product distribution. Recent 8-K reports furnish quarterly results and non-GAAP measures such as adjusted operating revenues, adjusted operating income, adjusted net operating income, diluted adjusted operating earnings per share, and adjusted stockholders’ equity, including treatment of IPO coinsurance transactions and investment gains or losses.
Proxy and governance filings cover director elections, executive compensation, pay-versus-performance data, board matters, and stockholder voting procedures. Other current reports document bylaw provisions for stockholder-requested special meetings and board composition disclosures.
Primerica director reports automatic phantom stock dividend reinvestment. On 12/15/2025, a company director acquired 12.6866 shares of phantom stock at $258.08 per share through dividends that were automatically reinvested under the Non-Employee Directors' Deferred Compensation Plan. After this transaction, the director beneficially owns 3,160.5934 shares of phantom stock in direct form. According to the plan, each phantom stock share is convertible into one share of Primerica common stock.
Primerica, Inc. reported that one of its directors acquired 30.5108 phantom stock units on 12/15/2025 through automatic dividend reinvestment under the Non-Employee Directors' Deferred Compensation Plan.
The phantom stock, which is convertible into common stock on a one-for-one basis under the plan, was credited at a price of $258.08 per unit, increasing the director's beneficial holdings to 8,430.8867 phantom stock units held directly.
A director of Primerica, Inc. (PRI) reported a small stock sale. On December 3, 2025, the director sold 700 shares of Primerica common stock at a price of $255 per share in an open market transaction coded as a sale. After this trade, the director continued to beneficially own 8,400.3759 shares directly. The filing is a routine ownership update and does not list any derivative securities activity.
Primerica Inc. filed a notice of proposed stock sale under Rule 144 for 700 shares of its common stock. The shares are planned to be sold through Citigroup Global Markets on the NYSE at an aggregate market value of $178,500. The securities were acquired on 12/03/2025 as stock from equity plans, with compensation listed as the form of payment. The notice includes a representation that the seller is not aware of any undisclosed material adverse information about Primerica’s current or prospective operations.
Primerica, Inc. (PRI) disclosed a routine insider stock transaction by its Chief Executive Officer, who is also a director. On 11/26/2025, the insider reported a transaction in Common Stock coded "G," indicating a gift or similar transfer of 4,000 shares at a stated price of $0 per share. After this transfer, the insider directly beneficially owns approximately 29,891.995 shares of Primerica common stock. The filing is made on Form 4 and reflects the holdings of a single reporting person.
Primerica, Inc. (PRI) reported an insider stock sale by a company officer who serves as President. On 11/17/2025, the reporting person sold 2,000 shares of Primerica common stock at an average price of $255.2998 per share, with individual trade prices ranging from $252.98 to $257.96. After this transaction, the insider directly beneficially owns 7,301 shares of Primerica common stock.
Primerica, Inc. (PRI) insider transaction: the Chief Executive Officer and Director reported selling 2,500 shares of common stock on 11/12/2025 at a weighted average price of $259.6477 per share. The filing notes multiple trade prices ranging from $258.05 to $261.40.
Following the sale, the reporting person beneficially owned 33,891.995 shares, held directly. The transaction is coded “S” for a sale.
Primerica, Inc. (PRI) received a Form 144 notice for a proposed sale of 2,500 common shares. The filing lists an aggregate market value of 639,325.00, an approximate sale date of 11/12/2025, execution on the NYSE, and Morgan Stanley Smith Barney as broker. The seller acquired the shares via Restricted Stock Awards on 03/01/2025.
Shares outstanding were 31,916,058 at the time referenced. Form 144 is a notice of intent to sell restricted or control securities and does not guarantee that sales will occur or in what amount.
Primerica (PRI) reported stronger results in its Q3 2025 10-Q. Total revenue rose to $839.9 million from $774.1 million a year ago, and net income increased to $206.8 million from $164.4 million. Diluted EPS from continuing operations was $6.35 versus $5.72. For the first nine months, revenue reached $2.44 billion and net income was $554.2 million.
Growth was broad-based. Term Life Insurance delivered income before taxes of $172.7 million as benefits and claims remained controlled and DAC amortization tracked policy growth. Investment & Savings Products posted income before taxes of $94.2 million on higher sales- and asset-based commissions. Corporate and Other contributed $4.8 million of pre-tax income.
The balance sheet showed total assets of $14.85 billion and stockholders’ equity of $2.30 billion. Year-to-date operating cash flow was robust at $562.9 million, supporting $380.0 million of share repurchases and $102.8 million in dividends. As of October 31, 2025, shares outstanding were 31,916,058.
Primerica, Inc. (PRI) furnished its third‑quarter update. The company announced results for the quarter ended September 30, 2025, via a press release furnished as Exhibit 99.1 and posted supplemental financial information as Exhibit 99.2 on its investor relations website.
The company highlighted several non‑GAAP measures used to evaluate performance: adjusted direct premiums, other ceded premiums, adjusted operating revenues, adjusted operating income before income taxes, adjusted net operating income, diluted adjusted operating earnings per share, and adjusted stockholders’ equity. Exclusions include amounts ceded under IPO coinsurance transactions, investment gains (losses) and mark‑to‑market adjustments, insurance proceeds tied to the 2021 e‑TeleQuote acquisition, corporate restructuring and related charges from the 2024 exit of the senior health business, related tax effects and a valuation allowance for e‑TeleQuote state NOLs, and certain unrealized AFS gains (losses) and discount‑rate impacts recorded in AOCI. Reconciliations are included with the press release. The information in Items 2.02 and 7.01 is furnished, not filed.